Abstract |
Tissue engineering holds great promise for the advancement of cardiovascular surgery as well as other medical fields. Tissue-engineered vascular grafts have the ability to grow and remodel and could therefore make great advances for pediatric cardiovascular surgery. In 2001, we began a human clinical trial evaluating these grafts in patients with a univentricular physiology. Herein, we report the long-term results of patients who underwent implantation of tissue-engineered vascular grafts as extracardiac total cavopulmonary conduits. Tissue-engineered vascular grafts seeded with autologous bone marrow mononuclear cells were implanted in 25 patients with univentricular physiology. The graft is composed of a woven fabric of poly-l-lactide acid or polyglycolic acid and a 50:50 poly (l-lactic-co-ε- caprolactone) copolymer. Patients were followed up with postoperatively in a multidisciplinary clinic. Median patient age at operation was 5.5 years and the mean follow-up period was 11.1 years. There was no graft-related mortality during the follow-up period. There was also no evidence of aneurysmal formation, graft rupture, graft infection, or calcification. Seven (28%) patients had asymptomatic graft stenosis and underwent successful balloon angioplasty. Stenosis is the primary complication of the tissue-engineered vascular graft. Avoidance of anticoagulation therapy would improve patients' quality of life. Tissue-engineered vascular grafts have feasibility in pediatric cardiovascular surgery.
|
Authors | Tadahisa Sugiura, Goki Matsumura, Shinka Miyamoto, Hideki Miyachi, Christopher K Breuer, Toshiharu Shinoka |
Journal | Seminars in thoracic and cardiovascular surgery
(Semin Thorac Cardiovasc Surg)
Vol. 30
Issue 2
Pg. 175-179
( 2018)
ISSN: 1532-9488 [Electronic] United States |
PMID | 29427773
(Publication Type: Clinical Trial, Journal Article, Video-Audio Media)
|
Copyright | Copyright © 2018 Elsevier Inc. All rights reserved. |
Chemical References |
- Polyesters
- poly(lactic acid-co-epsilon-caprolactone)
|
Topics |
- Adolescent
- Age Factors
- Angioplasty, Balloon
- Bioprosthesis
- Blood Vessel Prosthesis
- Blood Vessel Prosthesis Implantation
(adverse effects, instrumentation)
- Child
- Child, Preschool
- Computed Tomography Angiography
- Feasibility Studies
- Female
- Follow-Up Studies
- Fontan Procedure
(adverse effects, instrumentation)
- Graft Occlusion, Vascular
(diagnostic imaging, physiopathology, therapy)
- Heart Defects, Congenital
(diagnostic imaging, physiopathology, surgery)
- Humans
- Infant
- Male
- Polyesters
(chemistry)
- Prosthesis Design
- Quality of Life
- Stem Cell Transplantation
(adverse effects, methods)
- Time Factors
- Tissue Engineering
(methods)
- Tissue Scaffolds
- Treatment Outcome
- Vascular Patency
- Vena Cava, Inferior
(diagnostic imaging, physiopathology, surgery)
- Young Adult
|